Current options for treating airway hemangiomas include systemic and intralesional corticosteroids, interferon therapy, chemotherapy, use of lasers, open surgical excision, tracheotomy, sleeve resection, and selective artery embolization. The significant rates of complications described for these methods1,2 make the discovery of a novel therapy an attractive prospect. Several case reports and case series3-9 have recently appeared in the literature describing the use of propranolol as a highly effective option for the treatment of these airway lesions. Therefore, we reviewed the literature for information on the management of airway hemangiomas by performing a comprehensive PubMed search, focusing particularly on the use of propranolol in the treatment of airway hemangiomas, defined as occurring in the subglottis, trachea, and/or bronchi. We also describe a a 3-month-old boy with a large bronchial hemangioma that did not respond to propranolol therapy.
Sierpina DI, Chaudhary HM, Walner DL, Aljadeff G, Dubrow IW. An Infantile Bronchial Hemangioma Unresponsive to Propranolol Therapy: Case Report and Literature Review. Arch Otolaryngol Head Neck Surg. 2011;137(5):517–521. doi:10.1001/archoto.2011.67
Otolaryngology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.